Integrated HIV Care and Service Engagement among People Living with HIV who Use Drugs in a Setting with a Community-Wide Treatment as Prevention Initiative

Download PDF

It is well known that social and structural inequities, such as poverty and homelessness, can create barriers to routine HIV care among people living with HIV (PLHIV) who use drugs. Such barriers can contribute to poor HIV-related health outcomes among PLHIV who use drugs and undermine HIV treatment and prevention strategies. In British Columbia, treatment is offered universally upon diagnosis with HIV, as part of province-wide Treatment as Prevention (TasP) strategy.

Citation: Collins, A., Parashar, S., Hogg, R., Fernando, S., Worthington, C., McDougall, P., Baltzer Turje, R., & McNeil, R. (2017). Integrated HIV care and service engagement among people living with HIV who use drugs in a setting with a community-wide treatment as prevention initiative: a qualitative study in Vancouver, Canada. Journal of the International AIDS Society, 20(1).

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search